about
A comparison of different antibiotic regimens for the treatment of infective endocarditisAntibiotic therapy for treatment of infective endocarditisAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Methodology in improving antibiotic implementation policiesInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadIdentification of Small-Molecule Inhibitors against Meso-2, 6-Diaminopimelate Dehydrogenase from Porphyromonas gingivalisCost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in EuropeAntibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources.In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals."Ten Commandments" for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient SettingThe cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.Early treatment gains for antibiotic administration and within human host time series data.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenNasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers.Ultrastructural changes in methicillin-resistant Staphylococcus aureus induced by positively charged silver nanoparticlesVancomycin-Resistant Pseudomonas Aeroginosa in the Cases of Trauma.Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.Evaluation of Drug Treatment of Bronchopneumonia at the Pediatric Clinic in Sarajevo.Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy.Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Polybacterial human disease: the ills of social networking.Antibiotics in dental practice: how justified are we.Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls.Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.Using combination therapy to thwart drug resistance.The Effect of Preoperative Antimicrobial Prophylaxis on Intraoperative Culture Results in Patients with a Suspected or Confirmed Prosthetic Joint Infection: a Systematic Review.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.Critical review on retrospective and prospective changes in antifungal susceptibility testing for dermatophytes.Antimicrobial stewardship in wound care: a Position Paper from the British Society for Antimicrobial Chemotherapy and European Wound Management Association.Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine as Exemplified by the Swine Pathogen Streptococcus suis.Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use AntibioticsAnalysis of the third- and fourth-generation cephalosporin use for the treatment of infections caused by Gram-negative bacteria in hospital settings.A new approach to Vancomycin utilization evaluation: A cross-sectional study in intensive care unit.Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release.
P2860
Q24185887-37235F31-029C-471C-B0B5-059770C360A7Q24198788-CC60F822-F2CA-47AD-B91A-0962148440FFQ26739860-DF4F79D6-2075-4B9D-9604-061D6FC22F78Q26744801-2AD3E09A-3ACD-4C5E-BC52-6B60CE209479Q26822988-30FB07D9-D377-4D80-9834-C557846B2A2BQ28550756-C1979D09-6C1B-42F8-902E-E05FBD5443E5Q33617939-6E3771E2-FB66-4AB3-968C-8F5DF863470FQ34185105-523387A9-1638-4AC1-AB9C-2C6217C0315FQ34520194-483F62F2-F558-48A4-B0AF-2E538B6533B1Q35551018-E991D805-5C20-44EA-91C3-22D82094E6F0Q35575828-1ABDC15E-8C15-4FC7-BB45-2A0CFB7EFE15Q35861377-CE432B3F-6B7F-401A-B9BA-3E5ED456EA89Q36227029-F633D192-C7CE-49B6-9779-694D5B584CD6Q36322271-AA140105-D29D-4954-9400-DC85248B19B3Q36322918-A41E87AF-8645-4C60-952B-DA1E9C4A0B71Q36374592-CE8D318F-E701-431A-8B6A-2830EC258980Q36389808-4A54C3A0-CBED-49EF-876E-430BC9B1A621Q36654697-DC70CB71-A613-4926-BE7E-487717032603Q36686882-3DAC8C3E-3033-4A99-BBD2-D8A28671E4D4Q37229584-A4DA1C3C-A539-4FCB-BF59-3631BD8F0056Q37360042-3F3A889B-CCF8-4781-A369-A7C4B72D6FAFQ37411358-8E4C01C3-6809-44AB-A852-9691F8485AF9Q37576360-889B0C4C-3A42-4D3E-81FA-561C507D7B2EQ37653459-B158A7AB-01F6-420D-9D2B-1C7A0F9BEDB9Q38117077-E2B80E05-B9D3-4C32-BA4A-230C473F2231Q38220972-683D19A3-5984-4684-84A1-889BA0C8000DQ38289341-656E428B-B394-4984-87E7-92D7A850FE48Q38637507-7E5C284F-02B8-4260-AE52-947507069B92Q38641810-53ACADD9-5DE8-4916-B545-A81834A7AE9FQ38644503-83ECA4E0-B3E4-4D94-AF33-EE46B8A5601DQ38665464-3EDAEC81-9CB0-4AA7-9857-C9285CCD1740Q38696468-00280B2B-CF65-4AD9-8ACB-9ADBF2011048Q38714060-B5676DD0-734C-4D7A-9179-277799F5AED5Q38862785-3927ECDA-8B95-4124-B7A6-DC258FF04486Q38919687-36B7BC29-1EF3-4B98-ADC7-1F29AEBB9539Q38980023-5D7424F0-FE8C-42B7-9F2F-4E2CDEBEC08CQ38992886-1801F214-9CA7-4774-9825-005A91F55CD4Q39054761-F34902B2-3A57-43C4-BA8A-03160EDAA48FQ39187849-161F986E-2A07-497F-99A1-10C0F1347E94Q39517242-30724BD9-441E-46E4-B4B5-F8178CE26C6E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
General principles of antimicrobial therapy.
@ast
General principles of antimicrobial therapy.
@en
General principles of antimicrobial therapy.
@nl
type
label
General principles of antimicrobial therapy.
@ast
General principles of antimicrobial therapy.
@en
General principles of antimicrobial therapy.
@nl
prefLabel
General principles of antimicrobial therapy.
@ast
General principles of antimicrobial therapy.
@en
General principles of antimicrobial therapy.
@nl
P2093
P2860
P356
P1476
General principles of antimicrobial therapy.
@en
P2093
Christine L Terrell
Randall S Edson
Surbhi Leekha
P2860
P304
P356
10.4065/MCP.2010.0639
P407
P577
2011-02-01T00:00:00Z